Home » Slideshare - All Slideshows » The Evolution of Drug Development and Market Access via Connected Data-Driven Solutions

× Share this Presentation

Facebook
Twitter
Email
LinkedIn
Google+

First Name

Last Name

Company Name

Title

Country

Thank you for registering!

Error - something went wrong!

The Evolution of Drug Development and Market Access via Connected Data-Driven Solutions

November 1, 2017

Share this Presentation
Facebook
Twitter
Email
LinkedIn
Google+

The Connected Journey™ of data-driven services powered by PAREXEL® Analytics

Previous Presentation

Getting to Approval Faster Through Technology Innovation

PAREXEL's Matt Neal joins experts from Microsoft and Allergan to discuss how innovations in technology can ...

Next Presentation

So, My FitBit is Clinical Trial Grade Right?

So, My FitBit is Clinical Trial Grade Right? by PAREXEL's Keith Wenzel

Most Recent Presentations

Improving Processes for Temperature Traceability from Packaging to Patient

Check out this presentation from PAREXEL Randomization and Trial Supply Experts to learn about temperature monitoring practices throughout the clinical trial supply chain, including: traditional tempe

View Presentation

Life of a Biosimilar

Check out this presentation from PAREXEL Consulting experts to learn about key regulatory processes affecting biosimilars development including an an overview of the 351(k) Pathway, FDA approvals and

View Presentation

Effective Strategies for Successful Global Development

Learn how to leverage effective strategies for global drug development, including expedited regulatory pathways, personalized medicines and genomics. View the full presentation from PAREXEL Consulting

View Presentation

Trends in Early Development

PAREXEL Early Phase Clinical Research Services experts discuss developing trends in drug development including adaptive trials design, real-world data and biomarkers.

View Presentation

Understanding Regulatory and Payer Requirements Throughout Commercialization

Learn about regulator and payer evidence requirements as well as other key market access considerations in drug development. Read this presentation from PAREXEL Consulting experts.

View Presentation

Innovative Pricing and Reimbursement Schemes - The Why, What, Which & How

Learn about the need for innovation in global reimbursement mechanisms, the potential risks and benefits of implementation, and real world examples in a presentation by PAREXEL Access Consulting Exper

View Presentation

Leveraging Imaging and Wearable Technology For Agile Clinical Trials

Learn how to manage and overcome key challenges to deploying imaging and wearable technology effectively in clinical trials from PAREXEL Consulting experts.

View Presentation

Effective Regulatory Strategies for China Market Entry

Learn about the impact of China 's regulatory reforms for companies conducting clinical research in the country from PAREXEL Consulting experts.

View Presentation

Seamless Dataflow with a Clinical Metadata Repository

Learn how PAREXEL's Clinical Metadata Repository can help improve the way you manage clinical trial data.

View Presentation

FDA Initiatives Under The 21st Century Cures Act

Learn about FDA's priorities for implementing The 21st Century Cures Act and how they will impact clinical research from PAREXEL Consulting experts.

View Presentation

Exploring Ways to Enhance Evidence Generation & Communication Planning

PAREXEL experts explore key aspects of successful evidence generation and communication plans and how to apply them in your organization.

View Presentation

Operational Aspects of Independent Reviews for Immune-Oncology Clinical Endpoints

PAREXEL Consulting experts detail operational aspects of independent reviews in the context of immunotherapy clinical trials.

View Presentation

Development Considerations Comparing Major Markets Including US, EU, Japan and China

PAREXEL Consulting experts compare regulatory requirements in major drug development markets including the US, EU, Japan and China.

View Presentation

Understanding Different Stakeholder Requirements Throughout Commercialization

Learn how to use Real World Evidence (RWE) to bridge the evidence gap between regulators and payers.

View Presentation

RIM & IDMP Synergies

View the presentation to learn about RIM & IDMP synergies.

View Presentation

The Art and Science of Productive FDA Meetings

View the presentation to learn key strategies for optimizing meetings with the FDA.

View Presentation

Generating Evidence to Drive Patient Access

View this presentation to learn strategies for generating evidence that will help your product clear market access hurdles.

View Presentation

RIM & IDMP Synergies

View the presentation to learn about RIM & IDMP synergies.

View Presentation

Regulatory Strategy In Emerging Markets

PAREXEL Principal Consultant Angela McGillivary discusses commercial considerations, clinical development, regulatory requirements, submission and post approval strategies in emerging markets

View Presentation

Aligning on Patient Outcomes - How Market Dynamics Can Facilitate RWD Solutions

PAREXEL's Michelle Hoiseth on how pharmas can leverage Real-World Data to help improve patient outcomes.

View Presentation

Return to Home